“Intelligent Fingerprinting is a great system we can use in-house”

Specialist container logistics firm VKVP Haulage is now using the Intelligent Fingerprinting Drug Screening System. Random in-house drug testing using the fingerprint sweat-based testing approach will complement VKVP’s existing alcohol testing programme to support industry best practices across the company’s 80-strong HGV fleet of trucks.

The Intelligent Fingerprinting Drug Screening System is portable and works by analyzing fingerprint sweat. It is non-invasive, fast, and cost-effective, with sample collection taking seconds and simultaneous screening for multiple drug groups in ten minutes. Drugs tested include cocaine, methamphetamine, opiates, and cannabis. VKVP Haulage is initially carrying out random drug testing at its UK headquarters in Felixstowe; however, the VKVP Transport and Fleet Management team can extend testing to its other UK sites due to the system’s portability.

Roland Hollings, Transport & Fleet Manager at VKVP Haulage, said, “The Intelligent Fingerprinting Drug Screening System is a great testing solution we can use in-house as needed. The scenario training, the technology and its sample chain of custody make the fingerprint-based system particularly resilient, inspiring confidence from both our employees and customers.”

“We have only been drug testing with the system for a couple of weeks, but the power of random in-house testing is already having a positive impact, with both our workforce and our customers recognizing our commitment to having a proactive drug testing policy,” he added. “VKVP Haulage operates a fleet of 80 44-tonne articulated trucks that run across the country carrying containers for many of the UK’s leading brands, so it’s important we do as much as possible to ensure safe adherence to our Drug & Alcohol policy.”

“VKVP Haulage joins the growing number of transport and logistics operators who are increasingly turning to fingerprint-based testing to support their workplace drug policy and screening requirements,” said Philip Hand, Executive Chairman of Intelligent Fingerprinting. “VKVP is clearly committed to maintaining the high standards that its customers demand, and we’re proud the company has adopted fingerprint-based drug testing to support its operations.”

An introductory video demonstrating fingerprint-based drug testing in action is available here.

Intelligent Bio Solutions Signs South American Distribution Agreement with TSCOM for Fingerprint Drug Screening System and Secures First Order

Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company developing and delivering intelligent, rapid, non-invasive testing solutions, today announced it has signed a distribution agreement for its Intelligent Fingerprinting Drug Screening System with Chile-based company TSCOM SPA, increasing the product’s availability across South America. The Company further announced it received its first order under this agreement, coming from a Chile-based electrical distribution company.

The Intelligent Fingerprinting solution, which is widely recognized as the world’s first fingerprint-based drug testing system, analyzes fingerprint sweat to screen for recent drug use, including cannabis, cocaine, opiates, and methamphetamine. The innovative product provides a quick, easy, non-invasive and dignified alternative to traditional point-of-care drug testing methods, such as urine and saliva. The portable system enables workplace managers to conduct simple, non-intrusive testing anytime and almost anywhere, serving as a deterrent and encouraging employees to adhere to Health & Safety policies.

Pablo Riera, Director at TSCOM SPA, said, “At TSCOM, we’re looking forward to offering the innovative Intelligent Fingerprinting drug screening system to the South American market, and we’ll initially be targeting workplaces, government operations and healthcare providers across Chile. We have been tracking the increasing adoption of fingerprint-based drug screening for some while and believe the Intelligent Fingerprinting solution provides a great alternative for users of more traditional testing methods.”

TSCOM SPA will offer customers a comprehensive local service, from initial training to ongoing technical support and the re-supply of drug screening cartridges.

Mr. Riera added, “We’re seeing a lot of local interest in the innovative fingerprint-based test and have already won our first order from a Chile-based electrical distribution company for several readers. This customer quickly recognized the advantages of the fingerprint test system – easy-to-use, in-house, portable, non-invasive, and more hygienic than traditional alternatives. We are currently carrying out training and helping the client as they introduce fingerprint testing in their workplace.”

Harry Simeonidis, President and CEO of Intelligent Bio Solutions, commented, “Fingerprint drug testing is increasingly being regarded as the smart alternative for workplace drug screening. Since we acquired Intelligent Fingerprinting in Q3 2022, we have been working to expand our global reach for this innovative testing solution.  We are excited to extend our market reach into South America through our partnership with TSCOM SPA. We are thrilled they have moved so quickly to secure their first customer for our solution.”

INBS’s Intelligent Fingerprinting Drug Screening System comprises a small, tamper-evident drug screening cartridge onto which ten fingerprint sweat samples are collected in under a minute before the portable analysis unit provides an on-screen result in under ten minutes.

About TSCOM

Established over 10 years ago, TSCOM advises on and provides a comprehensive range of monitoring, security and detection solutions to support workplace health and safety, including drug and alcohol testing, GPS monitoring systems, and state-of-the-art security solutions.
For more information, visit: www.tscom.cl

European Freight Service Leader Rolls-out Fingerprint Drug Testing Solution

Cambridge, UK, June 29, 2023 — Palletways – Europe’s largest provider of express palletised distribution services – is rolling out the innovative Intelligent Fingerprinting drug testing system across its depot network.

Palletways is using the fingerprint drug test, which uses sweat to determine if employees have recently ingested illicit drugs that could affect their fitness to work, as part of its employee induction process.

The Company has purchased nine Intelligent Fingerprinting DSR-Plus fingerprint drug screening cartridge readers to make fingerprint drug testing readily available across its depot network. Sample collection using patented drug screening cartridges takes less than a minute, with an on-screen positive or negative drug screening result for each drug in the test available in just ten minutes via the portable DSR-Plus reader. Having access to the Intelligent Fingerprinting system in-house will also enable the Palletways team to test immediately in the rare occurrence of an accident to quickly eliminate if illicit drugs are present that could have affected the accident. Palletways is also purchasing Intoximeter alcohol tests for a combined workplace testing offer.

Kristie Hawkins, Manager of Palletways Birmingham Depot, said: “The company has a very good safety record, and introducing the highly visual Intelligent Fingerprinting Drug Test as part of the induction process is very important to us. We make sure that our new employees are tested for both drugs and alcohol as part of our induction process to introduce them proactively to our Drug and Alcohol Misuse Policy. Adherence to our policy helps prevent accidents for our employees and the general public while also supporting and protecting the reputation of our company.”

Palletways replaces saliva drug tests with a cleaner fingerprint method.

“The decision for Palletways to switch from using the old saliva swab test method to a simpler fingerprint test has been very well received,” adds Kristie. “The Intelligent Fingerprinting test is more hygienic for both the employee and the tester and is also less intrusive without compromising on performance. The change from swab testing to fingerprint testing has been well received across the Palletways depot network, with our employees and those responsible for testing appreciating its non-invasive nature.”

“Our Intelligent Fingerprinting drug testing solution is increasingly being chosen over more traditional approaches such as saliva and urine as it makes it much more hygienic to carry out in-house for-cause, random or pre-employment testing,” added Philip Hand, Executive Chairman of Intelligent Fingerprinting. “Palletways joins the growing list of transport and logistics specialists that are turning to fingerprint testing to support their workplace drug screening. A key factor driving this is the much shorter window of detection offered by fingerprint-based drug testing, meaning that firms can now provide much greater certainty about fitness for duty for their employees.

About Palletways

Founded in 1994, Palletways is Europe’s largest provider of express palletised distribution services. Palletways offers a strategically positioned network of depots, over 350 network members and hub operations in 20 countries, and offers an unrivalled ability to connect its customers’ businesses with the whole of Europe. https://www.palletwaysonline.com/en-gb

Intelligent Fingerprinting is a wholly owned subsidiary of Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Receives Guidance from U.S. FDA on a Regulatory Pathway for Expansion into the United States for its Intelligent Fingerprinting Drug Screening Cartridge

– Company intends to submit 510(k) pre-market notification to the FDA –

June 28, 2023 — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced it has received guidance from the U.S. Food and Drug Administration (the “FDA”) regarding the regulatory classification of its Intelligent Fingerprinting Drug Screening Cartridge. The FDA has provisionally determined that the cartridge falls within 21 CFR 862.3650, Opiate Test System, a Class II type device that requires the submission of a pre-market notification 510(k) and the FDA’s clearance prior to marketing. The preliminary assessment, in response to the Company’s March 2023 513(g) request for product classification, provides a clear regulatory pathway for INBS as part of the Company’s expansion strategy into the United States. The Company intends to submit a 510(k) pre-market notification for its proprietary Intelligent Fingerprinting Drug Screening Cartridge.

“We are pleased to receive the FDA’s preliminary assessment for our Intelligent Fingerprinting Drug Screening Cartridge, which is a key step in our expansion into the U.S. market,” said Harry Simeonidis, President and CEO of Intelligent Bio Solutions. “With its rapid collection time and portability, we believe our intelligent drug screening technology will redefine how U.S. workplaces approach testing by setting a new standard for drug testing procedures that prioritizes the dignity of employees while simultaneously enhancing operational efficiency for employers.”

The Intelligent Fingerprinting Drug Screening System is designed to detect the presence of specific drugs and/or their metabolites from fingerprint sweat. The system features a small, tamper-evident drug screening cartridge onto which ten fingerprint sweat samples are collected in less than a minute. The tamper-proof cartridges are designed to screen for multiple drug groups simultaneously, including combinations of opioids, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine, in an approach that offers a dignified, non-invasive, and rapid drug screening solution. The application of the technology in maintaining workplace safety has garnered positive feedback from the Company’s growing customer base of over 350 clients in other countries, successfully deterring substance abuse at work and ensuring employee well-being and compliance with health and safety policies.

About Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc. (the “Company”) (Nasdaq: INBS) is a medical technology company delivering intelligent, rapid, non-invasive testing solutions. The Company believes that its Intelligent Fingerprinting Drug Screening System will revolutionize portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields. This hygienic, and cost-effective system is designed to screen for recent use of drugs commonly found in the workplace, including opioids, cocaine, methamphetamine, and cannabis. With sample collection in seconds and results in under ten minutes, this technology would be a valuable tool for employers in safety-critical industries. Additionally, the Company’s biosensor platform has the potential to test for up to 130 indications, ranging from glucose to immunological conditions and communicable diseases. The Company’s current customer segments include construction, manufacturing and engineering, transport and logistics firms, drug treatment organizations, and coroners.

Intelligent Bio Solutions Plans to Add Fentanyl Testing as it Further Enhances its Fingerprint-Based Drug Screening Solution

Lab-testing pathway to expand capabilities of proprietary drug test screening to detect potent opioid fentanyl and fentanyl-adulterated street drugs

Opioid crisis estimated to be costing the U.S. $1.5 trillion annually; illicitly manufactured fentanyl by far the most commonly involved opioid in overdose deaths

May 16, 2023 — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced plans to add the potent synthetic opioid drug, fentanyl, and fentanyl-adulterated street drugs, to the panel of substances detected by its lab-based confirmation testing using fingertip sweat collected by its proprietary Intelligent Fingerprinting Drug Screening System.

According to CDC figures[1], U.S. overdose deaths were at a run rate of over 100,000 for the 12 months ended November 2022, with 81.9% of these deaths involving at least one opioid. Illicitly manufactured fentanyl is by far the most commonly involved opioid[2]. The Company is combatting this healthcare crisis by expanding the capabilities of its lab-based confirmation testing service to detect fentanyl and its related analogues in samples collected by its fingerprint-based drug testing system.

“By seeking to add fentanyl and other fentanyl-adulterated street drugs to our fingerprint-based lab-based confirmation drug testing panel, we are furthering our commitment to equipping workplaces to better combat the opioid issue. Fentanyl, and fentanyl-adulterated street drugs such as Tranq, continue to fuel an opioid crisis that the U.S. Joint Economic Committee estimates[3] is costing the country nearly $1.5 trillion a year and causing tragic impacts to many lives. We believe making drug testing for fentanyl non-invasive, quick, and hygienic is an important step towards addressing this crisis,” said Harry Simeonidis, President and CEO of Intelligent Bio Solutions.

The unique, non-invasive Intelligent Fingerprinting system features a hygienic, non-biohazardous collection cartridge that collects ten fingerprint sweat samples in under a minute. Fingerprint testing provides a quick and dignified approach that is much more convenient than traditional urine or saliva drug testing methods. Picogram levels of chemical sensitivity will allow the presence of fentanyl or fentanyl-adulterated street drugs to be identified by laboratory tests using Liquid Chromatography with tandem Mass Spectrometry (LC-MS/MS) analysis.

“Fentanyl is estimated to be around 50 times more potent than heroin, and detection can be challenging given that just 2mg of fentanyl is considered to be a fatal dose by the DEA[4]. Intelligent Fingerprinting’s proprietary testing approach features an advanced sample collection cartridge technology that is suitable for confirming the presence of fentanyl and street drugs through back-to-the-lab LC-MS/MS tests. This is an area that we believe could represent a significant market opportunity for INBS, both in the US and other international markets,” Mr. Simeonidis added.

In addition to its portability and ease-of-use, the non-invasive nature of the Intelligent Fingerprint drug test can also help provide early intelligence on cause of death, with fingerprint test samples providing evidence of recent use of opiates, methamphetamine, cocaine and cannabis.

[1] https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm

[2] https://www.cdc.gov/drugoverdose/fatal/dashboard/index.html

[3] https://www.jec.senate.gov/public/_cache/files/67bced7f-4232-40ea-9263-f033d280c567/jec-cost-of-opioids-issue-brief.pdf

[4] https://www.dea.gov/sites/default/files/2021-09/DEA_Fact_Sheet-Counterfeit_Pills.pdf

UK Food Processing Equipment Manufacturer Latest to Adopt Portable Fingerprint Drug Testing Solution

“Having experienced urine drug testing myself, I know it’s not a pleasant experience for anyone. So, when it came to selecting a drug screening approach for Dodman, it was clear that fingerprint testing was a major step forward for workplace drug testing.” – Chris Davies, Health and Safety Manager, Dodman

Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that UK manufacturer Dodman Limited (“Dodman”), specialists in the design, manufacture, installation and maintenance of processing systems for major food manufacturers, has selected INBS’s Intelligent Fingerprinting Drug Screening System to support random and for cause drug testing activities across its operations over traditional urine tests.

Dodman, a 30-year-old family business, sought to introduce drug testing proactively to protect and enhance its health and safety reputation. After assessing the workplace drug testing product market, Dodman’s Human Resources team selected the Intelligent Fingerprinting Drug Screening System.

The system comprises a small, tamper-evident drug screening cartridge onto which ten fingerprint sweat samples are collected in under a minute, before the portable analysis unit provides an on-screen result in under ten minutes. The system can be used in-house and screens the sweat for recent drug use, including cannabis, cocaine, opiates, and methamphetamine.

Intelligent Fingerprinting – Visual deterrent, positive competitive differentiator

Chris Davies, Health and Safety Manager at Dodman, commented, “For the first time, the portability of the Intelligent Fingerprinting system means that we can test employees both at our HQ operations as well as on-site at our clients’ food manufacturing facilities where our employees are involved in lifting to install, or servicing heavy machinery with sharp and potentially dangerous components. The Intelligent Fingerprinting system can be used on-site with results quickly available within minutes. It’s a great way of encouraging our employees to adhere to health and safety policies, and also is a strong differentiator for Dodman. Our clients’ like to see our approach to enforcing our Drug Policy, highlighting our commitment to health and safety on their sites as well as ours, and we’ve received positive feedback.”

Random drug testing – protecting business reputation

“We have introduced random drug testing with Intelligent Fingerprinting to protect and promote our reputation. We are constantly using fork lifts, spider, and gantry cranes, lifting heavy stainless steel components both in our factory and on-site for our blue-chip clients. We see introducing random employee drug testing – right across the business from our Managing Director down – as a proactive safety measure for all. With the increased use of drugs in society, we wanted to promote random drug testing to keep our employees safe and also to promote our company’s commitment to health and safety as a differentiator for current and future client contracts,” added Mr. Davies.

A better way than urine tests

“With my background in the military, I have experienced drug testing first-hand. Urine tests are unpleasant for all involved – there is nothing nice about them for the tester or the indignity for the candidate. As soon as I saw how quick, unintrusive and easy to use the Intelligent Fingerprinting drug testing system is, I knew it was the in-house system for Dodman. It is so quick and easy, I was surprised how it worked in the initial demo, but once the Intelligent Fingerprinting team explained the science to me, it all made absolute sense. We have every confidence in the system,” concluded Mr. Davies.

“We’re excited that Dodman has selected our Intelligent Fingerprinting solution to support their drug testing activities,” said Harry Simeonidis, President and CEO of Intelligent Bio Solutions. “While most companies recognize the importance of drug testing to help ensure employees’ safety, many people are simply uncomfortable with traditional urine drug testing methods. We are happy to offer an organization like Dodman an alternative method that is portable, quick, efficient and highly accurate.”

Intelligent Fingerprinting is a wholly-owned subsidiary of Intelligent Bio Solutions Inc.

Company’s 13^th patent granted strengthens protection for unique and proprietary Intelligent Fingerprinting point-of-care diagnostic drug screening technology

Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that  the Company has been granted a patent in the United Kingdom (UK) relating to its Intelligent Fingerprinting Drug Screening System DSR-Plus Cartridge Reader. This is the Company’s 13^th patent, which further strengthens the protection of its unique and proprietary drug screening technology.

UK Patent No: GB2592432, relates to the proprietary lateral flow test strip reading capability within the Company’s latest DSR-Plus cartridge reading unit. Designed and manufactured in the UK, the cartridge reader features a compact and portable specification that enables even simpler and faster drug testing. It provides organisations with rapid drug screening support wherever and whenever it’s needed. The DSR-Plus reader has been designed with no moving parts, ensuring resiliency when customers transport it between different sites, while improved battery life boosts screening productivity for human resources teams.

“We are very pleased to see that the hard work and dedication of the INBS team has resulted in this patent being granted for our proprietary fingerprint sweat-based technology,” commented Harry Simeonidis, President and CEO of Intelligent Bio Solutions. “This patent demonstrates the value of our innovative technology for the growing number of organisations looking to deter drug abuse in the workplace. It’s also extremely important for us to receive further protection for our intellectual property portfolio as we continue to expand our point-of-care diagnostic solutions business internationally.”

The non-invasive Intelligent Fingerprinting system comprises a small, tamper-evident drug screening cartridge onto which ten fingerprint sweat samples are collected in under a minute, before the portable DSR-Plus reader provides an on-screen result in less than ten minutes. The system can be used in-house and screens the sweat for recent drug use, including cannabis, cocaine, opiates, and methamphetamine.

About Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc. (the “Company”) (Nasdaq: INBS) is a medical technology company delivering intelligent, rapid, non-invasive testing solutions. The Company’s Intelligent Fingerprinting Drug Screening System is revolutionising portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields. This highly accurate, hygienic, and cost-effective system screens for recent use of drugs commonly found in the workplace, including opioids, cocaine, methamphetamine, and cannabis. With sample collection in seconds and results in under ten minutes, this technology is a valuable tool for employers in safety-critical industries. Additionally, the Company’s biosensor platform is being expanded to test for up to 130 indications, ranging from glucose to immunological conditions and communicable diseases. The Company’s current customer segments include construction, manufacturing and engineering, transport and logistics firms, drug treatment organisations, and coroners.

For more information, visit http://www.ibs.inc/

About Intelligent Fingerprinting

Intelligent Fingerprinting’s portable Drug Screening System works by analysing fingerprint sweat. It is non-invasive, fast, and cost-effective, with sample collection taking seconds and simultaneous screening for multiple drug groups in ten minutes. A laboratory confirmation service is also available. The system has applications within many sectors, and customers include employers in safety-critical industries such as construction, manufacturing and engineering, transport and logistics firms, drug treatment organisations, and coroners.

For more information, visit: www.intelligentfingerprinting.com

Investor Contact:

Valter Pinto, Managing Director
KCSA Strategic Communications
PH: (212) 896-1254
[email protected]

Media Contact:

Cheryl Billson
Comma Communications
[email protected]